{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:56:05Z","timestamp":1761490565604,"version":"3.37.3"},"reference-count":15,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,5,27]],"date-time":"2018-05-27T00:00:00Z","timestamp":1527379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:label\/><jats:p>Metachromatic leukodystrophy (<jats:styled-content style=\"fixed-case\">MLD<\/jats:styled-content>) is a rare progressive neurological disorder, often accompanied by motor impairments that are challenging to treat. In this case series, we report the course of treatment with intrathecal baclofen (<jats:styled-content style=\"fixed-case\">ITB<\/jats:styled-content>), aimed at improving daily care and comfort in children and young adults with <jats:styled-content style=\"fixed-case\">MLD<\/jats:styled-content>. All patients with <jats:styled-content style=\"fixed-case\">MLD<\/jats:styled-content> in our centre on <jats:styled-content style=\"fixed-case\">ITB<\/jats:styled-content> treatment for a minimum of 6 months were included (<jats:italic>n<\/jats:italic>=10; 4 males, 6 females; mean age 10y 8mo [range 6\u201324y]). Eight patients had <jats:styled-content style=\"fixed-case\">MLD<\/jats:styled-content> with a predominant spastic movement disorder (<jats:styled-content style=\"fixed-case\">sMLD<\/jats:styled-content>) and two were mainly dyskinetic. Patients with <jats:styled-content style=\"fixed-case\">sMLD<\/jats:styled-content> were compared with matched patients with spastic cerebral palsy (<jats:styled-content style=\"fixed-case\">CP<\/jats:styled-content>). Complication rates related to <jats:styled-content style=\"fixed-case\">ITB<\/jats:styled-content> treatment were similar in both groups. <jats:styled-content style=\"fixed-case\">ITB<\/jats:styled-content> treatment course in the first 6 months after pump implantation appears to show more dose increase in most patients <jats:styled-content style=\"fixed-case\">MLD<\/jats:styled-content>, compared to patients with spastic <jats:styled-content style=\"fixed-case\">CP<\/jats:styled-content>. This may be due to the progressive disease in <jats:styled-content style=\"fixed-case\">MLD<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">ITB<\/jats:styled-content> is a feasible therapy to improve daily care and comfort in patients with <jats:styled-content style=\"fixed-case\">MLD<\/jats:styled-content> and should therefore be considered early.<\/jats:p><\/jats:sec><jats:sec><jats:title>What this paper adds<\/jats:title><jats:p>\n<jats:list list-type=\"bullet\">\n\n<jats:list-item><jats:p>Intrathecal baclofen (ITB) is a feasible therapy to improve comfort and daily care in children and young people with metachromatic leukodystrophy (MLD).<\/jats:p><\/jats:list-item>\n\n<jats:list-item><jats:p>In the first 6 months of ITB treatment, MLD seems to show more dose increase compared to spastic cerebral palsy.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p><\/jats:sec>","DOI":"10.1111\/dmcn.13919","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T06:10:05Z","timestamp":1527487805000},"page":"232-235","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intrathecal baclofen in metachromatic leukodystrophy"],"prefix":"10.1111","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-856X","authenticated-orcid":false,"given":"Nikki","family":"van der Veldt","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine VU University Medical Center Amsterdam Movement Sciences Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane F","family":"van Rappard","sequence":"additional","affiliation":[{"name":"Department of Child Neurology Center for Childhood White Matter Disorders VU University Medical Center and Amsterdam Neuroscience Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A","family":"van de Pol","sequence":"additional","affiliation":[{"name":"Department of Child Neurology Center for Childhood White Matter Disorders VU University Medical Center and Amsterdam Neuroscience Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjo S","family":"van der Knaap","sequence":"additional","affiliation":[{"name":"Department of Child Neurology Center for Childhood White Matter Disorders VU University Medical Center and Amsterdam Neuroscience Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem J R","family":"van Ouwerkerk","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery VU University Medical Center Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jules G","family":"Becher","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine VU University Medical Center Amsterdam Movement Sciences Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole I","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Child Neurology Center for Childhood White Matter Disorders VU University Medical Center and Amsterdam Neuroscience Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5662-2843","authenticated-orcid":false,"given":"Annemieke I","family":"Buizer","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine VU University Medical Center Amsterdam Movement Sciences Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,5,27]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_6_2_1","DOI":"10.1038\/bmt.2008.275"},{"key":"e_1_2_6_3_1","first-page":"729","article-title":"Developing therapeutic approaches for metachromatic leukodystrophy","volume":"7","author":"Patil SA","year":"2013","journal-title":"Drug Des Devel Ther"},{"doi-asserted-by":"publisher","key":"e_1_2_6_4_1","DOI":"10.1016\/j.beem.2014.10.001"},{"doi-asserted-by":"publisher","key":"e_1_2_6_5_1","DOI":"10.1182\/blood-2016-03-708479"},{"doi-asserted-by":"publisher","key":"e_1_2_6_6_1","DOI":"10.1016\/S0140-6736(16)30374-9"},{"doi-asserted-by":"publisher","key":"e_1_2_6_7_1","DOI":"10.1017\/S0012162201001190"},{"doi-asserted-by":"publisher","key":"e_1_2_6_8_1","DOI":"10.1016\/S0140-6736(85)90541-0"},{"doi-asserted-by":"publisher","key":"e_1_2_6_9_1","DOI":"10.3171\/jns.2003.98.2.0291"},{"doi-asserted-by":"publisher","key":"e_1_2_6_10_1","DOI":"10.1016\/j.ejpn.2016.02.013"},{"doi-asserted-by":"publisher","key":"e_1_2_6_11_1","DOI":"10.1016\/j.ejpn.2011.07.008"},{"doi-asserted-by":"publisher","key":"e_1_2_6_12_1","DOI":"10.1111\/j.1469-8749.2010.03821.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_13_1","DOI":"10.1111\/dmcn.13602"},{"doi-asserted-by":"publisher","key":"e_1_2_6_14_1","DOI":"10.1097\/00006123-199605000-00015"},{"doi-asserted-by":"publisher","key":"e_1_2_6_15_1","DOI":"10.1007\/BF03086392"},{"doi-asserted-by":"publisher","key":"e_1_2_6_16_1","DOI":"10.1111\/j.1440-1754.2009.01601.x"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdmcn.13919","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dmcn.13919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:21:33Z","timestamp":1694719293000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dmcn.13919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,27]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1111\/dmcn.13919"],"URL":"https:\/\/doi.org\/10.1111\/dmcn.13919","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"type":"print","value":"0012-1622"},{"type":"electronic","value":"1469-8749"}],"subject":[],"published":{"date-parts":[[2018,5,27]]},"assertion":[{"value":"2018-04-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}